Controversies in contrast material?induced acute kidney injury: Propensity score matching of patients with different dose/absolute glomerular filtration rate ratios1

Radiology

Volumn 277, Issue 3, 2015, Pages 633-637

  Nyman, Ulf ^a   Aspelin, Peter ^b   Jakobsen, Jarl ^c   Björk, Jonas ^a,d  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; IODINATED CONTRAST MEDIUM; CONTRAST MEDIUM;

BODY SURFACE; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; GLOMERULUS FILTRATION RATE; HIGH RISK POPULATION; HUMAN; KIDNEY FUNCTION; META ANALYSIS (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPENSITY SCORE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; ACUTE KIDNEY FAILURE; CHEMICALLY INDUCED;

ACUTE KIDNEY INJURY; CONTRAST MEDIA; GLOMERULAR FILTRATION RATE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PROPENSITY SCORE; RISK FACTORS;

EID: 84948845793     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2015151341     Document Type: Review

References (42)

1. McDonald RJ, McDonald JS, Bida JP, et al. Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology 2013;267(1):106-118.
2. McDonald JS, McDonald RJ, Carter RE, Katzberg RW, Kallmes DF, Williamson EE. Risk of intravenous contrast materialmediated acute kidney injury: a propensity score-matched study stratified by baselineestimated glomerular filtration rate. Radiology 2014;271(1):65-73.
3. McDonald RJ, McDonald JS, Carter RE, et al. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. Radiology 2014;273(3):714-725.
4. Davenport MS, Khalatbari S, Cohan RH, Dillman JR, Myles JD, Ellis JH. Contrast material-induced nephrotoxicity and intraveresults nous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. Radiology 2013; 268(3):719-728.
5. Davenport MS, Khalatbari S, Dillman JR, Cohan RH, Caoili EM, Ellis JH. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material. Radiology 2013;267(1):94-105.
6. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013;3(1):1-150.
7. European Society of Urogenital Radiology. Contrast media guidelines. Version 8. 1. Web site. http://www. esur. org. Published May 2012. Accessed August 7, 2015.
8. Owen RJ, Hiremath S, Myers A, Fraser-Hill M, Barrett BJ. Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012. Can Assoc Radiol J 2014; 65(2):96-105.
9. Dong M, Jiao Z, Liu T, Guo F, Li G. Effect of administration route on the renal safety of contrast agents: a meta-analysis of randomized controlled trials. J Nephrol 2012;25(3):290-301.
10. McCullough PA, Brown JR. Effects of intra-arterial and intravenous iso-osmolar contrast medium (iodixanol) on the risk of contrastinduced acute kidney injury: a meta-analysis. Cardiorenal Med 2011;1(4):220-234.
11. Sherwin PF, Cambron R, Johnson JA, Pierro JA. Contrast dose-to-creatinine clearance ratio as a potential indicator of risk for radiocontrast-induced nephropathy: correlation of D/CrCL with area under the contrast concentration-time curve using iodixanol. Invest Radiol 2005;40(9):598-603.
12. Frennby B, Sterner G. Contrast media as markers of GFR. Eur Radiol 2002;12(2): 475-484.
13. Chen ML, Lesko L, Williams RL. Measures of exposure versus measures of rate and extent of absorption. Clin Pharmacokinet 2001; 40(8):565-572.
14. Nyman U, Björk J, Bäck SE, Sterner G, Grubb A. Estimating GFR prior to contrast medium examinations-what the radiologist needs to know! Eur Radiol 2015 May 28. [Epub ahead of print]
15. Nyman U, Grubb A, Larsson A, et al. The revised Lund-Malmö GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population. Clin Chem Lab Med 2014;52(6):815-824.
16. Newhouse JH, RoyChoudhury A. Quantitating contrast medium-induced nephropathy: controlling the controls. Radiology 2013; 267(1):4-8.
17. Davenport MS, Cohan RH, Khalatbari S, Ellis JH. The challenges in assessing contrastinduced nephropathy: where are we now? AJR Am J Roentgenol 2014;202(4):784-789.
18. Davenport MS, Cohan RH, Ellis JH. Contrast media controversies in 2015: imaging patients with renal impairment or risk of contrast reaction. AJR Am J Roentgenol 2015; 204(6):1174-1181.
19. Nyman U, Almén T, Aspelin P, Hellström M, Kristiansson M, Sterner G. Contrastmedium-induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min. Acta Radiol 2005; 46(8):830-842.
20. Nyman U, Björk J, Aspelin P, Marenzi G. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention. Acta Radiol 2008;49(6): 658-667.
21. Laskey WK, Jenkins C, Selzer F, et al. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 2007;50(7):584-590.
22. Gurm HS, Dixon SR, Smith DE, et al. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2011;58(9): 907-914.
23. Armstrong BG, Sloan M. Ordinal regression models for epidemiologic data. Am J Epidemiol 1989;129(1):191-204.
24. Nyman U, Almén T, Jacobsson B, Aspelin P. Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections? Eur Radiol 2012;22(6):1366-1371.
25. Myers GL, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006;52(1):5-18.
26. Stevens LA, Manzi J, Levey AS, et al. Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis 2007;50(1):21-35.
27. Miller WG, Myers GL, Ashwood ER, et al. Creatinine measurement: state of the art in accuracy and interlaboratory harmonization. Arch Pathol Lab Med 2005;129(3):297-304.
28. Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005;16(2):459-466.
29. Barrett BJ, Katzberg RW, Thomsen HS, et al. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol 2006;41(11):815-821.
30. Kuhn MJ, Chen N, Sahani DV, et al. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low-or isoosmolar contrast agent exposure. AJR Am J Roentgenol 2008;191(1): 151-157.
31. Nguyen SA, Suranyi P, Ravenel JG, et al. Isoosmolality versus low-osmolality iodinated contrast medium at intravenous contrastenhanced CT: effect on kidney function. Radiology 2008;248(1):97-105.
32. Thomsen HS, Morcos SK, Erley CM, et al. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol 2008;43(3):170-178.
33. Bruce RJ, Djamali A, Shinki K, Michel SJ, Fine JP, Pozniak MA. Background fluctuation of kidney function versus contrast-induced nephrotoxicity. AJR Am J Roentgenol 2009;192(3):711-718.
34. Ronco C, Stacul F, McCullough PA. Subclinical acute kidney injury (AKI) due to iodinebased contrast media. Eur Radiol 2013; 23(2):319-323.
35. Filiopoulos V, Biblaki D, Lazarou D, et al. Plasma neutrophil gelatinase-associated lipocalin (NGAL) as an early predictive marker of contrast-induced nephropathy in hospitalized patients undergoing computed tomography. Clin Kidney J 2013;6(6):578-583.
36. Kooiman J, van de Peppel WR, Sijpkens YW, et al. No increase in Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin excretion following intravenous contrast enhanced-CT. Eur Radiol 2015;25(7):1926-1934.
37. Lacquaniti A, Buemi F, Lupica R, et al. Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy? Radiology 2013;267(1):86-93.
38. American College of Radiology Manual on Contrast Media. Version 10. Web site. http://www. acr. org/quality-safety/resources/ contrast-manual. Published 2015. Accessed August 7, 2015.
39. Kristiansson M, Holmquist F, Nyman U. Ultralow contrast medium doses at CT to diagnose pulmonary embolism in patients with moderate to severe renal impairment: a feasibility study. Eur Radiol 2010;20(6):1321-1330.
40. Noda Y, Kanematsu M, Goshima S, et al. Reducing iodine load in hepatic CT for patients with chronic liver disease with a combination of low-tube-voltage and adaptive statistical iterative reconstruction. Eur J Radiol 2015;84(1):11-18.
41. Lehti L, Nyman U, Söderberg M, Björses K, Gottsäter A, Wassélius J. 80-kVp CT angiography for endovascular aneurysm repair follow-up with halved contrast medium dose and preserved diagnostic quality. Acta Radiol 2015 Mar 30. [Epub ahead of print]
42. Johnson PT, Naidich D, Fishman EK. MDCT for suspected pulmonary embolism: multi-institutional survey of 16-MDCT data acquisition protocols. Emerg Radiol 2007;13(5):243-249.